Raymond James & Associates Sells 477,197 Shares of BlackRock Capital Allocation Term Trust (NYSE:BCAT)

Raymond James & Associates lowered its position in BlackRock Capital Allocation Term Trust (NYSE:BCAT) by 80.5% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 115,443 shares of the company’s stock after selling 477,197 shares during the period. Raymond James & Associates owned approximately 0.11% of BlackRock Capital Allocation Term Trust worth $1,894,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also modified their holdings of the business. Transcend Capital Advisors LLC raised its stake in shares of BlackRock Capital Allocation Term Trust by 7.3% during the second quarter. Transcend Capital Advisors LLC now owns 65,207 shares of the company’s stock valued at $1,070,000 after acquiring an additional 4,435 shares in the last quarter. Alpine Global Management LLC lifted its position in shares of BlackRock Capital Allocation Term Trust by 11.9% in the 1st quarter. Alpine Global Management LLC now owns 151,000 shares of the company’s stock worth $2,516,000 after purchasing an additional 16,000 shares during the period. Advisors Asset Management Inc. boosted its stake in shares of BlackRock Capital Allocation Term Trust by 9.1% during the first quarter. Advisors Asset Management Inc. now owns 189,291 shares of the company’s stock valued at $3,154,000 after purchasing an additional 15,763 shares in the last quarter. Ironsides Asset Advisors LLC increased its holdings in shares of BlackRock Capital Allocation Term Trust by 14.1% in the 1st quarter. Ironsides Asset Advisors LLC now owns 29,133 shares of the company’s stock valued at $485,000 after acquiring an additional 3,606 shares during the period. Finally, Oppenheimer & Co. Inc. grew its stake in BlackRock Capital Allocation Term Trust by 18.6% in the first quarter. Oppenheimer & Co. Inc. now owns 29,180 shares of the company’s stock valued at $486,000 after purchasing an additional 4,586 shares during the last quarter. Hedge funds and other institutional investors own 36.12% of the company’s stock.

BlackRock Capital Allocation Term Trust Price Performance

BCAT stock opened at $16.49 on Wednesday. BlackRock Capital Allocation Term Trust has a one year low of $13.67 and a one year high of $17.18. The firm has a 50-day simple moving average of $16.38 and a two-hundred day simple moving average of $16.12.

BlackRock Capital Allocation Term Trust Increases Dividend

The business also recently disclosed a monthly dividend, which was paid on Friday, August 30th. Stockholders of record on Thursday, August 15th were issued a dividend of $0.287 per share. The ex-dividend date of this dividend was Thursday, August 15th. This represents a $3.44 annualized dividend and a dividend yield of 20.89%. This is an increase from BlackRock Capital Allocation Term Trust’s previous monthly dividend of $0.29.

BlackRock Capital Allocation Term Trust Profile

–